Details for 2014745722
Up to date per 01.04.2026
Actions
Details for 2014745722
Granted/Registered
European Patent
09.12.2015 A
04.04.2018 B1
31.01.2013
US
201361759123 P
C07D 471/04 20060101AFI20160428BHEP
Owner
GlaxoSmithKline Intellectual Property (No. 3) LimitedGSK Medicines Research Centre, Gunnels Wood Road Stevenage SG1 2NYGB
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
BUON, Christophe7171 Frederick-Banting Montréal, Québec H4S 1Z9CA
CANTIN, Louis-David7171 Frederick-Banting Montréal, Québec H4S 1Z9CA
HU, Yun-Jin7171 Frederick-Banting Montréal, Québec H4S 1Z9CA
LUO, Xuehong7171 Frederick-Banting Montréal, Québec H4S 1Z9CA
TOMASZEWSKI, Miroslaw Jerzy7171 Frederick-Banting Montréal, Québec H4S 1Z9CA
Information about Fees